Elevating the cardiac standard of care
Bardy Diagnostics (bardydx.com) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 42nd percentile of 12137 Healthcare brands.
Bardy Diagnostics, founded in 2013 and headquartered in Seattle, United States, is a healthcare technology company specializing in ambulatory ECG monitoring. Its flagship product, the Carnation Ambulatory Monitor, is a lightweight, extended-wear cardiac patch designed to optimize P-wave signal capture for improved diagnostic clarity. Developed by a physician, the device targets healthcare professionals and cardiologists seeking accurate, comfortable, and reliable cardiac monitoring solutions. The company positions itself as a leader in ambulatory ECG technology, emphasizing clinical diagnostic accuracy and customer service.
| Brand Name | Bardy Diagnostics |
|---|---|
| Domain | bardydx.com |
| Industry | Healthcare, Technology |
| Founded | 2013 |
| Headquarters | Seattle, United States |
| Main Competitors | iRhythm Technologies (81/100), Philips Healthcare (82/100), Preventice Solutions (BioTelemetry) (77/100), Medtronic (83/100), GE Healthcare (89/100), AliveCor (89/100) |
Moz Domain Authority 26/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,182,588 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Elevating the cardiac standard of care with award-winning ECG technologies, high clinical diagnostic accuracy, and quality customer care." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), YouTube, Instagram; no detected presence on LinkedIn, Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Bardy Diagnostics?", Claude could identify the brand as of September 2026. Bardy Diagnostics is a medical device company known for developing the Carnation Ambulatory Monitor (CAM) patch, a wearable ECG monitoring device used to detect cardiac arrhythmias like atrial fibrillation. The company was founded by Dr. Gust Bardy and was later acquired by Hill- Best known for The Carnation Ambulatory Monitor (CAM), a patch-based long-term ECG monitor for arrhythmia detection.
When asked "Best brands similar to Bardy Diagnostics?", Claude would recommend Bardy Diagnostics as of September 2026. It's a notable player in the ambulatory cardiac monitoring space, often mentioned alongside companies like iRhythm (Zio patch) when discussing wearable ECG monitoring solutions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Bardy Diagnostics's main competitors in Healthcare: iRhythm Technologies (81/100), Philips Healthcare (82/100), Preventice Solutions (BioTelemetry) (77/100), Medtronic (83/100), GE Healthcare (89/100).
Sources: Brand Analyzer scan
Bardy Diagnostics offers the Carnation Ambulatory Monitor, a lightweight, extended-wear cardiac patch designed for ambulatory ECG monitoring. The device is engineered to optimize P-wave signal capture, aiming to provide superior diagnostic clarity for cardiac conditions compared to conventional ECG monitoring solutions.
Sources: Bardy Diagnostics official site
Bardy Diagnostics is a healthcare technology company based in Seattle, United States, founded in 2013, that specializes in ambulatory ECG (electrocardiogram) monitoring devices for cardiac diagnostics.
Sources: Bardy Diagnostics official site
Bardy Diagnostics has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 45, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Bardy Diagnostics official site
Bardy Diagnostics was founded in 2013. Bardy Diagnostics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Bardy Diagnostics develops and provides ambulatory ECG monitoring technology, most notably the Carnation Ambulatory Monitor, a wearable cardiac patch that captures extended-duration ECG data to help clinicians diagnose cardiac conditions with high accuracy.
Sources: Bardy Diagnostics official site
Bardy Diagnostics scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Bardy Diagnostics official site
Bardy Diagnostics is known for its Carnation Ambulatory Monitor, a lightweight, extended-wear ECG patch engineered specifically to optimize P-wave signal capture, which the company states was developed by a physician to improve diagnostic clarity for cardiac conditions.
Sources: Bardy Diagnostics official site
Bardy Diagnostics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Bardy Diagnostics official site
Bardy Diagnostics' products are used by healthcare professionals, cardiologists, and clinicians who require accurate, comfortable, and reliable ambulatory cardiac monitoring solutions for their patients.
Sources: Bardy Diagnostics official site
Bardy Diagnostics scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Bardy Diagnostics has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,182,588 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 26/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Bardy Diagnostics from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Bardy Diagnostics: Barco Uniforms (75/100), Bahmni (75/100), Bastyr University (75/100), BAS (Benefit Allocation Systems) (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.